Prostaglandin E₂ promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation

References

• Zammit PS, Partridge TA, Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 2006; 54:1177-91; PMID:16899758; https://doi.org/10.1369/jhc.6R6995.2006
   PubMed Web of Science ®Google Scholar
• Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol 2013; 14:518-28; PMID:23877564; https://doi.org/10.1038/nrm3629
   PubMed Web of Science ®Google Scholar
• Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36:131-49; PMID:12814430; https://doi.org/10.1046/j.1365-2184.2003.00266.x
   PubMed Web of Science ®Google Scholar
• Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 2008; 7:33-44; PMID:18177723; https://doi.org/10.1016/j.cmet.2007.11.011
   PubMed Web of Science ®Google Scholar
• Ji M, Zhang Q, Ye J, Wang X, Yang W, Zhu D. Myostatin induces p300 degradation to silence cyclin D1 expression through the PI3K/PTEN/Akt pathway. Cell Signal 2008; 20:1452-8; PMID:18472397; https://doi.org/10.1016/j.cellsig.2008.03.013
   PubMedGoogle Scholar
• Yang W, Zhang Y, Li Y, Wu Z, Zhu D. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 β pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 2007; 282:3799-808; PMID:17130121; https://doi.org/10.1074/jbc.M610185200
   PubMed Web of Science ®Google Scholar
• Langley B, Thomas M, McFarlane C, Gilmour S, Sharma M, Kambadur R. Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway. Oncogene 2004; 23:524-34; PMID:14724580; https://doi.org/10.1038/sj.onc.1207144
   PubMed Web of Science ®Google Scholar
• Tormos AM, Talens-Visconti R, Nebreda AR, Sastre J. p38 MAPK: a dual role in hepatocyte proliferation through reactive oxygen species. Free Radic Res 2013; 47:905-16; PMID:23906070; https://doi.org/10.3109/10715762.2013.821200
   PubMed Web of Science ®Google Scholar
• Macleod KF. The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system. Nat Rev Cancer 2008; 8:769-81; PMID:18800074; https://doi.org/10.1038/nrc2504
   PubMedGoogle Scholar
• Zaccagnini G, Martelli F, Magenta A, Cencioni C, Fasanaro P, Nicoletti C, Biglioli P, Pelicci PG, Capogrossi MC. p66(ShcA) and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ischemia. J Biol Chem 2007; 282:31453-9; PMID:17726026; https://doi.org/10.1074/jbc.M702511200
   PubMedGoogle Scholar
• Luczak K, Balcerczyk A, Soszynski M, Bartosz G. Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int 2004; 28:483-6; PMID:15223026; https://doi.org/10.1016/j.cellbi.2004.03.004
   PubMed Web of Science ®Google Scholar
• Jansen KM, Pavlath GK. Prostaglandin F2alpha promotes muscle cell survival and growth through upregulation of the inhibitor of apoptosis protein BRUCE. Cell Death Differ 2008; 15:1619-28; PMID:18566603; https://doi.org/10.1038/cdd.2008.90
   PubMedGoogle Scholar
• Horsley V, Pavlath GK. Prostaglandin F2(α) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J Cell Biol 2003; 161:111-8; PMID:12695501; https://doi.org/10.1083/jcb.200208085
   PubMedGoogle Scholar
• Bondesen BA, Jones KA, Glasgow WC, Pavlath GK. Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion. FASEB J 2007; 21:3338-45; PMID:17488951; https://doi.org/10.1096/fj.06-7070com
   PubMedGoogle Scholar
• Velica P, Khanim FL, Bunce CM. Prostaglandin D2 inhibits C2C12 myogenesis. Mol Cell Endocrinol 2010; 319:71-8; PMID:20109525; https://doi.org/10.1016/j.mce.2010.01.023
   PubMedGoogle Scholar
• Mo C, Romero-Suarez S, Bonewald L, Johnson M, Brotto M. Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat Biotechnol 2012; 6:223-9; PMID:23092433; https://doi.org/10.2174/1872208311206030223
   PubMedGoogle Scholar
• Otis JS, Burkholder TJ, Pavlath GK. Stretch-induced myoblast proliferation is dependent on the COX2 pathway. Exp Cell Res 2005; 310:417-25; PMID:16168411; https://doi.org/10.1016/j.yexcr.2005.08.009
   PubMed Web of Science ®Google Scholar
• Rundhaug JE, Simper MS, Surh I, Fischer SM. The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev 2011; 30:465-80; PMID:22012553; https://doi.org/10.1007/s10555-011-9317-9
   PubMed Web of Science ®Google Scholar
• Breyer RM. Prostaglandin EP(1) receptor subtype selectivity takes shape. Mol Pharmacol 2001; 59:1357-9; PMID:11353793
   PubMed Web of Science ®Google Scholar
• De Keijzer S, Meddens MB, Torensma R, Cambi A. The Multiple Faces of Prostaglandin E2 G-Protein Coupled Receptor Signaling during the Dendritic Cell Life Cycle. Int J Mol Sci 2013; 14:6542-55; PMID:23528886; https://doi.org/10.3390/ijms14046542
   PubMed Web of Science ®Google Scholar
• Mori A, Ito S, Morioka M, Aso H, Kondo M, Sokabe M, Hasegawa Y. Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca(2+) concentrations in human airway smooth muscle cells. Eur J Pharmacol 2011.
   Web of Science ®Google Scholar
• Loffler I, Grun M, Bohmer FD, Rubio I. Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2. BMC Cancer 2008; 8:380; PMID:19099561; https://doi.org/10.1186/1471-2407-8-380
   PubMedGoogle Scholar
• Murn J, Alibert O, Wu N, Tendil S, Gidrol X. Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4. J Exp Med 2008; 205:3091-103; PMID:19075289; https://doi.org/10.1084/jem.20081163
   PubMed Web of Science ®Google Scholar
• Kimura M, Osumi S, Ogihara M. Prostaglandin E(2) (EP(1)) receptor agonist-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: the involvement of TGF-α. Endocrinology 2001; 142:4428-40; PMID:11564707
   PubMed Web of Science ®Google Scholar
• Barbieri E, Sestili P. Reactive oxygen species in skeletal muscle signaling. J Signal Transduct 2012; 2012:982794; PMID:22175016; https://doi.org/10.1155/2012/982794
   PubMedGoogle Scholar
• Xia D, Holla VR, Wang D, Menter DG, DuBois RN. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Res 2010; 70:824-31; PMID:20068165; https://doi.org/10.1158/0008-5472.CAN-09-2105
   PubMedGoogle Scholar
• Doherty GA, Byrne SM, Molloy ES, Malhotra V, Austin SC, Kay EW, Murray FE, Fitzgerald DJ. Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer. BMC Cancer 2009; 9:207; PMID:19558693; https://doi.org/10.1186/1471-2407-9-207
   PubMed Web of Science ®Google Scholar
• Stewart ZA, Leach SD, Pietenpol JA. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol Cell Biol 1999; 19:205-15; PMID:9858545
   PubMed Web of Science ®Google Scholar
• Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol 2013; 1:45-9; PMID:24024136; https://doi.org/10.1016/j.redox.2012.10.001
   PubMed Web of Science ®Google Scholar
• Li X, Fang P, Mai J, Choi ET, Wang H, Yang XF. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol 2013; 6:19; PMID:23442817; https://doi.org/10.1186/1756-8722-6-19
   PubMed Web of Science ®Google Scholar
• Lin JK, Tsai SH. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Repub China B 1999; 23:99-106; PMID:10492890
   PubMedGoogle Scholar
• Pizarro JG, Folch J, Vazquez De la Torre A, Verdaguer E, Junyent F, Jordan J, Pallas M, Camins A. Oxidative stress-induced DNA damage and cell cycle regulation in B65 dopaminergic cell line. Free Radic Res 2009; 43:985-94; PMID:19657808; https://doi.org/10.1080/10715760903159188
   PubMed Web of Science ®Google Scholar
• Meng D, Shi X, Jiang BH, Fang J. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic Biol Med 2007; 42:1651-60; PMID:17462533; https://doi.org/10.1016/j.freeradbiomed.2007.01.037
   PubMedGoogle Scholar
• Hole PS, Pearn L, Tonks AJ, James PE, Burnett AK, Darley RL, Tonks A. Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34+ hematopoietic progenitor cells. Blood 2010; 115:1238-46; PMID:20007804; https://doi.org/10.1182/blood-2009-06-222869
   PubMed Web of Science ®Google Scholar
• Chess PR, O'Reilly MA, Sachs F, Finkelstein JN. Reactive oxidant and p42/44 MAP kinase signaling is necessary for mechanical strain-induced proliferation in pulmonary epithelial cells. J Appl Physiol (1985) 2005; 99:1226-32; PMID:15890751; https://doi.org/10.1152/japplphysiol.01105.2004
   PubMedGoogle Scholar
• Barbieri E, Sestili P. Reactive oxygen species in skeletal muscle signaling. J Signal Transduct 2012; 2012:982794; PMID:22175016; https://doi.org/10.1155/2012/982794
   PubMedGoogle Scholar
• Lalier L, Cartron PF, Pedelaborde F, Olivier C, Loussouarn D, Martin SA, Meflah K, Menanteau J, Vallette FM. Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme. Oncogene 2007; 26:4999-5009; PMID:17369862; https://doi.org/10.1038/sj.onc.1210303
   PubMedGoogle Scholar
• Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl−2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58:362-6; PMID:9443418
   PubMed Web of Science ®Google Scholar
• Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011; 16:123-40; PMID:21251164; https://doi.org/10.1111/j.1365-2443.2010.01473.x
   PubMed Web of Science ®Google Scholar
• Huang J, Hsu YH, Mo C, Abreu E, Kiel DP, Bonewald LF, Brotto M, Karasik D. METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-kappaB signaling pathway. J Bone Miner Res 2014; 29:1531-40; PMID:24677265; https://doi.org/10.1002/jbmr.2200
   PubMed Web of Science ®Google Scholar
• Khan A, Gillis K, Clor J, Tyagarajan K. Simplified evaluation of apoptosis using the Muse cell analyzer. Postepy Biochem 2012; 58:492-6; PMID:23662443
   PubMedGoogle Scholar